Return on Equity: The amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. Calculated as: Income from Continuing Operations / Total Common Equity
Anebulo Pharmaceuticals, Inc. (ANEB) had Return on Equity of -12.45% for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
-- |
|
$-1.68M |
|
-- |
|
-- |
|
$1.89M |
|
$-1.89M |
|
$0.22M |
|
$-1.68M |
|
$-1.68M |
|
$-1.68M |
|
$-1.68M |
|
$-1.68M |
|
$-1.68M |
|
$-1.89M |
|
$-1.65M |
|
41.09M |
|
41.09M |
|
$-0.04 |
|
$-0.04 |
|
| Balance Sheet Financials | |
$13.81M |
|
-- |
|
$0.20M |
|
$14.01M |
|
$0.55M |
|
-- |
|
-- |
|
$0.55M |
|
$13.46M |
|
$13.46M |
|
$13.46M |
|
41.09M |
|
| Cash Flow Statement Financials | |
$-4.70M |
|
-- |
|
$14.88M |
|
$3.09M |
|
$13.28M |
|
$10.19M |
|
$1.11M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
25.29 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-4.70M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
|
Return on Equity |
-12.45% |
-12.45% |
|
-11.97% |
|
-12.45% |
|
$0.33 |
|
$-0.11 |
|
$-0.11 |
|